← Back
$WHWK All transactions

Whitehawk Therapeutics, Inc.

A

$ Value

$0

Shares

55,309

Price

$0

Filed

Dec 2

Insider

Name

Dugan Margaret

Title

Chief Medical Officer

CIK

0001909734

Roles

Officer

Transaction Details

Transaction Date

2025-12-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

55,309

Footnotes

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 1, 2025. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 1, 2025.

Filing Info

Accession No.

0001909734-25-000006

Form Type

4

Issuer CIK

0001422142

Dugan Margaret's History

Date Ticker Type Value
2026-04-01 WHWK A $0
2025-12-01 WHWK A $0
2025-12-01 WHWK A $0
2025-10-16 SDGR $29K
2025-05-21 BGNE A $0
2025-05-21 BGNE A $0

Other Insiders at WHWK (90d)

Insider Bought Sold Last
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
$882K 2026-04-16
BALL BRYAN
See remarks
$635K 2026-04-14
Dornan David
Chief Scientific Officer
2026-04-01
Dugan Margaret
Chief Medical Officer
2026-04-01
Lennon David James
CHIEF EXECUTIVE OFFICER
$1.0M 2026-04-09